MedTrace Logo

Possibilities and Limitations of a New Method for the Measurement of Spine Dynamics During Gait

NCT01803256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-11-28

No results posted yet for this study

Summary

The full body marker sets that are typically used in opto-electronic 3D gait analyses either disregard the spine entirely or regard it as a rigid structure. Therefore, the purpose of this study is to identify the possibilities and limitations of an enhanced trunk marker set for the measurement of spine dynamics during gait in adolescents with and without structural spine deformities.

It has been hypothesized that the enhance trunk marker set:

1. is a valid method for the measurement of spine deformations in the sagittal, frontal and indirectly transverse planes.
2. is an applicable and reliable method for the measurement of spine dynamics during gait in healthy adolescents and in patients with structural deformities such as seen in scoliosis.
3. is sensitive enough to distinguish the spinal movement pattern during gait measured in scoliosis patients from the one measured in healthy adolescents.

To verify the hypotheses, the following measurements will be carried out:

* Biplanar radiographs (a-p and lateral) with radio-opaque markers in scoliosis patients.
* Instrumented gait analysis with a standard full body marker set and the enhanced trunk marker set in scoliosis patients and healthy controls.

Conditions

  • Scoliosis

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • Bern University of Applied Sciences

    collaborator OTHER

  • University Children's Hospital Basel

    lead OTHER

Principal Investigators

  • Reinald Brunner, MD · University Children's Hospital Basel

  • Stefan Schmid, PT, PhD · Swiss Federal Institute of Technology / Bern University of Applied Sciences

  • Silvio Lorenzetti, PhD, DSc · Swiss Federal Institute of Technology

  • Jacqueline Romkes, PhD · University Children's Hospital Basel

  • Carol-Claudius Hasler, MD · University Children's Hospital Basel

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-09-30
Completion
2016-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01803256 on ClinicalTrials.gov